1. Auvinen, A., Rietbergen, J. B. W., Denis, L. J., Schröder, F. H. & Prorok, P. C. (1996). A prospective evaluation plan for randomised trials of prostate cancer screening. J Med Screening 3: 97–104.
2. Auvinen, A., Hakama, M., Vornanen, T., Leppilahti, M., Ala-Opas, M., Salminen, P. & Tammela, T. (1998). A randomised trial of choice of treatment in prostate cancer. (submitted for publication)
3. Breslow, N. E., Chan, C. W., Dhom, G., Drury, R. A. B., Franks, L. M., Gellei, B., Lee, Y. S., Lundberg, S., Sparke, B., Sternby, N. H. & Tulinius, H. (1977). Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 20: 680–688.
4. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. A., Yuan, J. J., Petros, J. A. & Andriole, G. L. (1991). Measurement of prostate-specific antigen in serum as screening test for prostate cancer. N Engl J Med 324: 1156–1161.
5. Day, N. E., Walter, S. D., Tabár, L., Fagerberg, C. J. G. & Collette, H. J. A. (1988). The sensitivity and lead time of breast cancer screening: a comparison of the results of different studies. In Screening for Breast Cancer, Day NE and Miller AB (eds). International Union Against Cancer and Hans Huber Publishers; Stuttgart